TG Therapeutics
TGTX
TGTX
236 hedge funds and large institutions have $3.73B invested in TG Therapeutics in 2021 Q2 according to their latest regulatory filings, with 45 funds opening new positions, 87 increasing their positions, 70 reducing their positions, and 46 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
17% less funds holding in top 10
Funds holding in top 10: 6 → 5 (-1)
22% less capital invested
Capital invested by funds: $4.76B → $3.73B (-$1.03B)
26% less call options, than puts
Call options by funds: $61.6M | Put options by funds: $83.8M
Holders
236
Holding in Top 10
5
Calls
$61.6M
Puts
$83.8M
Top Buyers
| 1 | +$63.6M | |
| 2 | +$39.5M | |
| 3 | +$27.4M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$23.3M |
| 5 |
PAMU
Pictet Asset Management (UK)
London,
United Kingdom
|
+$21.7M |
Top Sellers
| 1 | -$72.5M | |
| 2 | -$50.2M | |
| 3 | -$36.7M | |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
-$32M |
| 5 |
AG
Artal Group
Luxembourg
|
-$27.2M |